Meryem BEKMEZCİ, OĞUZHAN GÜNENC

The role of neutrophil/ lymphocyte ratio (NLR) with ca 125 in preoperative predictıon of malignancy in adnexial mass

It is aimed to evaluate the neutrophil / lymphocyte ratio (NLR) and platelet / lymphocyte ratio (PLR) values with CA 125 value in order to distinguish benign / malign / borderline tumors in patients undergoing surgery for adnexal mass. In this retrospective study were included 290 randomized patients having adnexal mass. According to the results of postoperative pathology, 227 patients were benign and 63 were malign. Hematological parameters such as NLR, mean platelet volume (MPV), and PLR were measured in the preoperative period. Multivariate regression analysis was performed statistically to determine the association with CA 125 and hematologic parameters of malignancy in adnexal masses. Women with malignant adnexal mass were older than the ones having benign adnexal mass. CA 125, NLR and PLR levels were statistically higher in patients having malignant adnexal mass than the ones having benign adnexal mass. Age, CA 125 and NLR were associated with malignancy in women with adnexal mass. Multivariable logistic regression analysis depicted that age, CA 125 and NLR were related to increased malignancy risk in adnexal mass (OR=1.047, 95 %Cl =1.023-1.071, OR=1.007, 95 %Cl = 1.004-1.010 and OR=1.228, 95 %Cl = 1.032-1.460, respectively). CA 125, NLR and PLR were positively correlated to malignancy in women with adnexal mass. The CA125 value alone is insufficient for malignancy discrimination. Combination of it with age, and NLR may be useful in distinguishing malignant masses from benign ones in the preoperative period.

PDF

___

Halazun KJ, Hardy MA, Rana AA, et al. Negative impact of neutrophillymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250:141-51.

Hafeez S, Sufian S, Beg M, et al. Role of ultrasound in characterization of ovarian masses. Asian Pac J Cancer Prev. 2013;14:603-6.

Arab M, Yaseri M, Ashrafganjoi T, et al. Comparison of two ovarian malignancy prediction models based on age sonographic findings and serum CA125 measurement. Asian Pac J Cancer Prev.2012;13:4199-202.

Toriola AT, Grankvist K, Agborsangaya CB, et al. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol. 2011;22:1916-21.

Acmaz G, Aksoy H, Unal D, et al. Are neutrophil/ lymphocyte and platelet/ lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer. Prev. 2014;15:1689-92.

National Cancer Institute Cancer Stat Facts, Ovarian CancerAvailable from URL: https://seer.cancer.gov/statfacts/html/ovary.html aaccessed date 20.09.2017

Yildirim MA, Seckin KD, Togrul C, et al. Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses. Asian Pac J Cancer Prev. 2014;15:6881-5.

Kokcu A, Kurtoglu E, Celik H, et al. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer? Asian Pac J Cancer Prev. 2014;15:9781-4.

Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol. 2005;99:267-77.

Maggino T, Gadducci A, D’Addario V, et al. Prospective multicenter study on CA125 in postmenopausal pelvic masses. Gynecol Oncol. 1994;54:117-23.

Serov SF, Scully RE, Sobin LH. International histological classification of tumors: No 9, histological typing of ovarian tumors. Geneva, Switzerland: World Health Organization.1973;

National Institutes of Health Consensus Development Conference Statement Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994;55:4-14.

Myers ER, Bastian LA, Havrilesky LJ, et al. Management of adnexal mass. Evid Rep Technol Assess (Full Rep). 2006;130:1-145.

Romagnolo C, Leon AE, Fabricio ASC, et al. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study. Gynecol Oncol. 2006;141:303-11.

Campos C, Sarian LO, Jales RM, et al. Performance of the Risk of malignancy index for discriminating malignant tumors in women with adnexal masses. J Ultrasound Med. 2016;35:143-52.

Yanaranop M, Tiyayon J, Siricharoenthai S, et al. Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass. Gynecol Oncol. 2016;141:479-84.

Tamussino KF, Gucer F, Reich O, et al Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer. 2001;11:236-40.

Kuyumcuoglu U, Guzel AI, Celik Y, et al. The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol. 2010;31:514-6.

Yang H, Zhu L, Wang S, et al. Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125. J Minim Invasive Gynecol. 2013;10:300-2.